Why Key Account Management Matters for a Successful Pharma Product Launch

Not every large organization should automatically become a key account. Selection should consider factors such as patient opportunity, treatment influence, access dynamics, strategic importance, and the ability to create meaningful value.

Stakeholder mapping

Large healthcare organizations can contain multiple stakeholders with different priorities. A KAM model should identify who influences clinical, operational, financial, and access decisions.

Cross-functional governance

Sales, medical affairs, market access, marketing, and other teams should not approach the same account with disconnected objectives.

Account planning

Each priority account needs a clear understanding of its current state, opportunities, barriers, stakeholders, actions, and desired outcomes.

Performance measurement

KAM should be connected to measurable outcomes rather than activity alone. Metrics might include account access, adoption, engagement quality, stakeholder progress, or achievement of agreed commercial objectives.

Building KAM Into a Pharma Product Launch

A practical launch model can be organized around three phases.

Pre-launch: Understand the account